Sponsor or institution
Clinical trials and research at Hydrogene Therapeutics INC
As of November 12, 2026, Find a Trial lists 3 NIH-funded research projects at this institution, with $2.4 million in listed awards. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 3NIH research projects
NIH-funded research (3)
Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.
-
Non-viral gene therapy approach to permanently fix hemophilia B
A new gene therapy approach aims to permanently correct hemophilia B without using viruses, potentially reducing bleeding events for people with this condition.
-
Hydrodynamic gene delivery through the bile ducts for Wilson’s disease
Aimed at delivering a functional ATP7B gene variant to the liver using a special bile-duct delivery method to help people with Wilson’s disease avoid liver transplant.
-
Correcting hereditary tyrosinemia type 1 and other liver diseases using gene therapy.
This study is testing a new way to treat hereditary tyrosinemia type 1 (HT1) by using a special gene therapy that delivers healthy genes directly to the liver, which could help patients avoid liver transplants and long-term medications.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.